Talphera (TLPH) Net Equity Issued and Repurchased (2010 - 2023)

Talphera's (TLPH) quarterly Net Equity Issued and Repurchased came in at -$68000.0 in Q4 2023, down 134.0% quarter-over-quarter from $200000.0 in Q3 2022.

Talphera (TLPH) Net Equity Issued and Repurchased (2010 - 2023) Analysis & Trends

Talphera's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at -$68000.0 for Q4 2023.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$68000.0 in Q4 2023; TTM through Dec 2024 was $132000.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $8.9 million, up 3605.44% from the prior year.
  • Net Equity Issued and Repurchased declined to -$68000.0 in Q4 2023 per TLPH's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $36.4 million in Q1 2021 and bottomed at -$36.4 million in Q3 2021.
  • The 5-year median for Net Equity Issued and Repurchased is $1.0 million (2019), against an average of $3.0 million.
  • Biggest YoY gain for Net Equity Issued and Repurchased was 4537.76% in 2021; the steepest drop was 465.39% in 2021.
  • Year by year, Net Equity Issued and Repurchased stood at $1.2 million in 2019, then jumped by 705.92% to $9.9 million in 2020, then plunged by 465.91% to -$36.4 million in 2021, then soared by 100.55% to $200000.0 in 2022, then tumbled by 134.0% to -$68000.0 in 2023.
  • Per Business Quant, the three latest TLPH Net Equity Issued and Repurchased figures stand at -$68000.0 (Q4 2023), $200000.0 (Q3 2022), and -$36.4 million (Q3 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -68,000.00
Dec 31, 2023 -68,000.00
Sep 30, 2022 200,000.00
Sep 30, 2022 200,000.00
Sep 30, 2021 -36.36 Mn
Sep 30, 2021 -36.36 Mn
Jun 30, 2021 7.50 Mn
Jun 30, 2021 7.50 Mn
Mar 31, 2021 36.36 Mn
Mar 31, 2021 36.36 Mn
Dec 31, 2020 9.94 Mn
Dec 31, 2020 9.94 Mn
Sep 30, 2020 9.95 Mn
Sep 30, 2020 9.95 Mn
Jun 30, 2020 665,000.00
Jun 30, 2020 665,000.00
Mar 31, 2020 784,000.00
Mar 31, 2020 784,000.00
Sep 30, 2019 1.23 Mn
Sep 30, 2019 1.23 Mn